One of these utilizes the antigen PRAME (preferentially expressed in melanoma) involved in retinoic acid receptor repression although expressed in low levels in many normal tissues and is overexpressed in both melanoma and NSCLC and therefore a vaccination target. Here, PRAME is linked to melanoma.